IL118644A - N-¬(1,4-diazabicyclo¬2.2.2¾oct-2-YL)methyl¾benzamide derivatives their preparation and their application in therapeutics - Google Patents

N-¬(1,4-diazabicyclo¬2.2.2¾oct-2-YL)methyl¾benzamide derivatives their preparation and their application in therapeutics

Info

Publication number
IL118644A
IL118644A IL11864496A IL11864496A IL118644A IL 118644 A IL118644 A IL 118644A IL 11864496 A IL11864496 A IL 11864496A IL 11864496 A IL11864496 A IL 11864496A IL 118644 A IL118644 A IL 118644A
Authority
IL
Israel
Prior art keywords
diazabicyclo
therapeutics
derivatives
preparation
application
Prior art date
Application number
IL11864496A
Other languages
English (en)
Other versions
IL118644A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL118644A0 publication Critical patent/IL118644A0/xx
Publication of IL118644A publication Critical patent/IL118644A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11864496A 1995-06-13 1996-06-12 N-¬(1,4-diazabicyclo¬2.2.2¾oct-2-YL)methyl¾benzamide derivatives their preparation and their application in therapeutics IL118644A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506951A FR2735475B1 (fr) 1995-06-13 1995-06-13 Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IL118644A0 IL118644A0 (en) 1996-10-16
IL118644A true IL118644A (en) 2000-02-17

Family

ID=9479885

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11864496A IL118644A (en) 1995-06-13 1996-06-12 N-¬(1,4-diazabicyclo¬2.2.2¾oct-2-YL)methyl¾benzamide derivatives their preparation and their application in therapeutics

Country Status (19)

Country Link
US (1) US5663173A (es)
EP (1) EP0748807A1 (es)
JP (1) JPH09118680A (es)
KR (1) KR970001335A (es)
CN (1) CN1143644A (es)
AR (1) AR004669A1 (es)
AU (1) AU704388B2 (es)
CA (1) CA2178849A1 (es)
CO (1) CO4700470A1 (es)
CZ (1) CZ171696A3 (es)
FR (1) FR2735475B1 (es)
HU (1) HUP9601620A3 (es)
IL (1) IL118644A (es)
NO (1) NO305251B1 (es)
NZ (1) NZ286805A (es)
PL (1) PL314745A1 (es)
SK (1) SK75296A3 (es)
TW (1) TW372238B (es)
ZA (1) ZA964985B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756564B1 (fr) * 1996-12-04 2004-05-14 Synthelabo Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique
FR2756563B1 (fr) * 1996-12-04 1998-12-24 Synthelabo Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
KR100619639B1 (ko) * 1997-11-07 2006-09-06 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
JP2002518352A (ja) * 1998-06-15 2002-06-25 セプラコア インコーポレーテッド 無呼吸、過食症およびその他の障害を治療するための光学的に純粋な（＋）−ノルシスアプリドの使用
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
ES2237117T3 (es) 1998-06-15 2005-07-16 Sepracor Inc. Uso de (-)norcisaprida opticamente pura en el tratamiento del sindrome del intestino irritable.
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
WO2005118537A2 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Arylpiperazine derivatives as adrenergic receptor antagonists
US8071605B2 (en) 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections
JP5549847B2 (ja) * 2009-11-16 2014-07-16 東ソー株式会社 Ｎ−（２−アルコキシメチル）トリエチレンジアミン類の製造法
GB201219820D0 (en) 2012-11-05 2012-12-19 Isis Innovation Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
ES2135414T3 (es) * 1991-09-12 1999-11-01 Smithkline Beecham Plc Antagonistas del receptor 5-ht4.
TW282460B (es) * 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd

Also Published As

Publication number Publication date
CO4700470A1 (es) 1998-12-29
US5663173A (en) 1997-09-02
MX9602306A (es) 1997-10-31
HUP9601620A3 (en) 1998-07-28
EP0748807A1 (fr) 1996-12-18
CA2178849A1 (en) 1996-12-14
NZ286805A (en) 1998-03-25
IL118644A0 (en) 1996-10-16
JPH09118680A (ja) 1997-05-06
CN1143644A (zh) 1997-02-26
SK75296A3 (en) 1997-05-07
PL314745A1 (en) 1996-12-23
ZA964985B (en) 1997-01-23
FR2735475A1 (fr) 1996-12-20
AU704388B2 (en) 1999-04-22
KR970001335A (ko) 1997-01-24
FR2735475B1 (fr) 1997-07-11
HUP9601620A2 (en) 1997-01-28
CZ171696A3 (en) 1997-01-15
NO962477D0 (no) 1996-06-12
NO305251B1 (no) 1999-04-26
AU5591296A (en) 1997-01-02
NO962477L (no) 1996-12-16
TW372238B (en) 1999-10-21
AR004669A1 (es) 1999-03-10
HU9601620D0 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
EP0728749A3 (en) Triazine derivatives, their preparation and their application
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
IL111148A0 (en) Imidazol-4- ylpiperidine derivatives, their preparation and their application in therapeutics
HUP9801910A3 (en) Dolastatin derivatives, their preparation and use
ZA978089B (en) 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics.
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
IL118644A (en) N-¬(1,4-diazabicyclo¬2.2.2¾oct-2-YL)methyl¾benzamide derivatives their preparation and their application in therapeutics
AU7095296A (en) Phosphorylamides, their preparation and use
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
IL118485A (en) 5,6-dihydro-9H-pyrazolo¬3,4-c¾-1,2,4-triazolo¬4,3-a¾ pyridines and pharmaceutical compositions containing them
HUP9904206A3 (en) 1,4-diazabicyclo[2.2.2.]oct-2-ylmethyl derivatives,their preparation and therapeutic application
ZA986786B (en) 4-oxo-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide-derivatives their preparation and their application in therapeutics
IL131645A (en) Pyrimido ¬1,2-a¾indole derivatives and their preparation
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
HK1005553A1 (en) Reactive dyes, their preparation and use thereof
ZA972894B (en) Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics.
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
SG49960A1 (en) Dyes, processes for their preparation and their use
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
ZA966616B (en) Benzenesulphonamide derivatives, their preparation and their application in theraphy.
ZA961983B (en) Bicyclic compounds, preparation thereof and use in pharmaceutical compositions.
ZA963620B (en) (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use.
ZA977767B (en) Benzylamine derivatives, their preparation and their application in therapeutics.
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees